Summary
Radioimmunoassays for erythropoietin are limited so far to a few specialized laboratories and this requires transport and storage of samples. We therefore tested the stability of immunoreactive erythropoietin in serum and plasma samples obtained from a uremic and a nonuremic anemic patient. No significant change in the concentration of immunoreactive erythropoietin was found in either serum or plasma samples for up to 14 days of storage. This type of stability was observed no matter whether the samples were stored at room temperature, 4° C, or −20° C. There was no difference between the estimates of erythropoietin in serum and heparinized plasma. Validity of the radioimmunoassay used in this study was demonstrated by parallelism of dilution curves of test specimens and the 2nd International Reference Preparation for erythropoietin and by a close correlation between the immunoreactivity and the bioactivity of the hormone, as assessed in the same samples by the exhypoxic polycythemic mouse bioassay.
In conclusion the data obtained clearly indicate that the necessity of storage and transport of clinical samples does not limit the practicability of the radioimmunoassay for erythropoietin.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- EPO:
-
erythropoietin
- irEPO:
-
immunoreactive erythropoietin
- IRP:
-
International Reference Preparation
- hct:
-
hematocrit
- rhEPO:
-
recombinant human erythropoietin
- RIA:
-
radioimmunoassay
References
Chard T (1982) An introduction to radioimmunoassay and related techniques, 2nd edn. Elsevier Biomedical, Amsterdam, New York, Oxford, p 177
Cotes PM (1982) Immunoreactive erythropoietin in serum. Br J Haematol 50:427–438
Cotes PM, Bangham DR (1961) Bio-assay of erythropoietin in mice made polycythaemic by exposure to air at a reduced pressure. Nature 4793:1065–1067
Erslev AJ, Wilson J, Caro J (1987) Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 109:429–433
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73–78
Espada J, Brandan NC, Dorado M (1973) Effect of chemical and enzymatic agents on the biological activity of erythropoietin. Acta Physiol Lat Am 23:193–201
Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME, Cronkite EP (1982) Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. J Lab Clin Med 99:624–635
Rambach WA, Alt HL, Cooper JAD (1957) The mode of action and nature of a heat stable plasma erythropoietic factor. Blood 12:1101–1113
Winearls CG, Pippard MJ, Downing MR, Oliver DO, Reid C, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis. Lancet 8517:1175–1178
Zyznar ES (1981) A rationale for the application of trasylol as a protease inhibitor in radioimmunoassay. Life Sci 28:1861–1866
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eckardt, K.U., Kurtz, A., Hirth, P. et al. Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klin Wochenschr 66, 241–245 (1988). https://doi.org/10.1007/BF01748163
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01748163